Eton Pharmaceuticals: Q1 Earnings Insights

Shares of Eton Pharmaceuticals ETON moved higher in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share increased 138.00% year over year to $0.19, which were in line with the estimate of $0.19.

Revenue of $11,897,000 up by 11917.17% year over year, which missed the estimate of $12,050,000.

Outlook

Eton Pharmaceuticals hasn't issued any earnings guidance for the time being.

Eton Pharmaceuticals hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: May 13, 2021

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/x2v7aoim

Technicals

Company's 52-week high was at $10.30

Company's 52-week low was at $4.33

Price action over last quarter: down 1.87%

Company Overview

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!